Adani Ports breaks out at record Rs 1,747 as 500 MMT milestone meets Hormuz reroute trade (NSE: ADANIPORTS)
Why ASX retail investors are watching Energy Resources of Australia (ASX: ERA) collapse to the Rio Tinto buyout floor
Read More Pharma Industry News Inhibrx Biosciences’ Ozekibart sets new benchmark in rare bone cancer treatment and advances toward 2026 BLA filing Find out how Inhibrx Biosciences’ Ozekibart delivered breakthrough results in chondrosarcoma and is advancing toward a 2026 BLA filing—read more now! bySoujanya RaviOctober 24, 2025